India Court Questions 10-Fold Hospital Drug Markups

Concerns about unpredictable medical bills and weak price transparency are surfacing across health systems. In India, the Supreme Court has challenged steep hospital markups on cancer medicines and asked the government to consider broader limits, while advocates warn that uninsured patients may pay more than people covered by negotiated insurer or public-scheme rates; medical representatives counter that treatment costs vary by patient. In Luxembourg, proposed rules meant to preserve payment and reimbursement arrangements after doctors’ and dentists’ agreements with the National Health Fund ended have drawn legal objections over patient charges and coverage, with officials working to avert a gap. In the United States, a discussion of new research examines how the No Surprises Act and its dispute-resolution process may affect emergency-care reimbursement and spending.